{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:11:15Z","timestamp":1781910675196,"version":"3.54.5"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Portal hypertension monitoring is important throughout the natural course of cirrhosis. Hepatic venous pressure gradient (HVPG), regarded as the golden standard, is limited by invasiveness and technical difficulties. Portal hypertension is increasingly being assessed non-invasively, and hematological indices, imaging data, and statistical or computational models are studied to surrogate HVPG. This paper discusses the existing non-invasive methods based on measurement principles and reviews the methodological developments in the last 20 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>First, we used VOSviewer to learn the architecture of this field. The publications about the non-invasive assessment of portal hypertension were retrieved from the Web of Science Core Collection (WoSCC). VOSviewer 1.6.17.0 was used to analyze and visualize these publications, including the annual trend, the study hotspots, the significant articles, authors, journals, and organizations in this field. Next, according to the cluster analysis result of the keywords, we further retrieved and classified the related studies to discuss.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,088 articles or review articles about our topic were retrieved from WoSCC. From 2000 to 2022, the number of publications is generally growing. \u201cWorld Journal of Gastroenterology\u201d published the most articles (<jats:italic>n<\/jats:italic> = 43), while \u201cJournal of Hepatology\u201d had the highest citations. \u201cLiver fibrosis\u201d published in 2005 was the most influential manuscript. Among the 20,558 cited references of 1,088 retrieved manuscripts, the most cited was a study on liver stiffness measurement from 2007. The highest-yielding country was the United States, followed by China and Italy. \u201cBerzigotti, Annalisa\u201d was the most prolific author and had the most cooperation partners. Four study directions emerged from the keyword clustering: (1) the evaluation based on fibrosis; (2) the evaluation based on hemodynamic factors; (3) the evaluation through elastography; and (4) the evaluation of variceal bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The non-invasive assessment of portal hypertension is mainly based on two principles: fibrosis and hemodynamics. Liver fibrosis is the major initiator of cirrhotic PH, while hemodynamic factors reflect secondary alteration of splanchnic blood flow. Blood tests, US (including DUS and CEUS), CT, and magnetic resonance imaging (MRI) support the non-invasive assessment of PH by providing both hemodynamic and fibrotic information. Elastography, mainly USE, is the most important method of PH monitoring.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.960316","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T08:40:46Z","timestamp":1663231246000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"XiaoHan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bo","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Aljbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian Hang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-017-9827-9","article-title":"The portal hypertension syndrome: etiology, classification, relevance, and animal models.","author":"Bosch","year":"2018","journal-title":"Hepatol Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/s0140-6736(08)60383-9","article-title":"Liver Cirrhosis.","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension.","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis.","volume":"57","author":"Garc\u00eda-Pag\u00e1n","year":"2012","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right.","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology."},{"key":"B7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.21090","article-title":"Hepatic venous pressure gradient identifies patients at risk of severe hepatitis c recurrence after liver transplantation.","volume":"43","author":"Blasco","year":"2006","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1478-3231.2008.01711.x","article-title":"Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis b virus.","volume":"28","author":"Kumar","year":"2008","journal-title":"Liver Int."},{"key":"B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","article-title":"Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.","volume":"50","author":"Ripoll","year":"2009","journal-title":"J Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis.","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastroesophageal varices and variceal bleeding.","volume":"5","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of Variceal Rebleeding.","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/hep.28031","article-title":"The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique.","volume":"62","author":"Silva-Junior","year":"2015","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B16","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20871","article-title":"Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the meld era.","volume":"42","author":"Ripoll","year":"2005","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno Vii - Renewing Consensus in Portal Hypertension.","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","article-title":"U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.","volume":"64","author":"Tripathi","year":"2015","journal-title":"Gut."},{"key":"B19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Easl clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the american association for the study of liver diseases.","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of hvpg measurements in chronic liver disease.","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jhep.2020.10.003","article-title":"Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.","volume":"74","author":"Ferrusqu\u00eda-Acosta","year":"2021","journal-title":"J Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.gie.2020.06.065","article-title":"Eus-Guided portal pressure gradient measurement in patients with acute or subacute portal hypertension.","volume":"93","author":"Zhang","year":"2021","journal-title":"Gastrointest Endosc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.gie.2021.11.037","article-title":"Simultaneous eus-guided portosystemic pressure measurement and liver biopsy sampling correlate with clinically meaningful outcomes.","volume":"95","author":"Hajifathalian","year":"2022","journal-title":"Gastrointest Endosc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future.","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments.","author":"Bosch","year":"2015","journal-title":"J Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","article-title":"Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.","volume":"144","author":"Berzigotti","year":"2013","journal-title":"Gastroenterology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1016\/j.cgh.2020.03.034","article-title":"Deep convolutional neural network-aided detection of portal hypertension in patients with cirrhosis.","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e890","DOI":"10.1016\/j.cgh.2021.04.030","article-title":"Hepquant shunt detects portal hypertension in early stages of clinically compensated chronic liver disease.","volume":"20","author":"Wieland","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3748\/wjg.v22.i12.3441","article-title":"Osteopontin: a non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.","volume":"22","author":"Bruha","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.5009\/gnl14345","article-title":"Clinical implications of the serum apelin level on portal hypertension and prognosis of liver cirrhosis.","volume":"10","author":"Lim","year":"2016","journal-title":"Gut Liver."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14498","article-title":"Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.","volume":"40","author":"Simbrunner","year":"2020","journal-title":"Liver Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/hep.29557","article-title":"Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis c.","volume":"67","author":"Mauro","year":"2018","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2007.02.006","article-title":"Vascular endothelial dysfunction in cirrhosis.","volume":"46","author":"Iwakiri","year":"2007","journal-title":"J Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2362.2007.01814.x","article-title":"Adma correlates with portal pressure in patients with compensated cirrhosis.","volume":"37","author":"Vizzutti","year":"2007","journal-title":"Eur J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/hep.25806","article-title":"Von willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.","volume":"56","author":"Ferlitsch","year":"2012","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149230","article-title":"The vitro score (von willebrand factor antigen\/thrombocyte ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including elf test.","volume":"11","author":"Hametner","year":"2016","journal-title":"PLoS One."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14218\/jcth.2018.00036","article-title":"A meta-analysis of the value of vwf in the diagnosis of liver cirrhosis with portal hypertension.","volume":"7","author":"Ding","year":"2019","journal-title":"J Clin Transl Hepatol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025656","article-title":"Von willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis.","volume":"9","author":"Zou","year":"2019","journal-title":"BMJ Open."},{"key":"B40","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Easl clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/hep.26755","article-title":"Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients.","volume":"59","author":"Buck","year":"2014","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease.","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jceh.2018.09.006","article-title":"The macrophage activation marker soluble cd163 is associated with early allograft dysfunction after liver transplantation.","volume":"9","author":"Thomsen","year":"2019","journal-title":"J Clin Exp Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1136\/gut.2010.234542","article-title":"Kupffer cells are activated in cirrhotic portal hypertension and not normalised by tips.","volume":"60","author":"Holland-Fischer","year":"2011","journal-title":"Gut."},{"key":"B45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2036.2012.05134.x","article-title":"Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.","volume":"36","author":"Gr\u00f8nbaek","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/apt.13618","article-title":"The macrophage activation marker scd163 combined with markers of the enhanced liver fibrosis (elf) score predicts clinically significant portal hypertension in patients with cirrhosis.","volume":"43","author":"Sandahl","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2029674","article-title":"Circulating microbiome in patients with portal hypertension.","volume":"14","author":"Gedgaudas","year":"2022","journal-title":"Gut Microb."},{"key":"B48","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.1096\/fj.201901327R","article-title":"Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.","volume":"33","author":"Juanola","year":"2019","journal-title":"FASEB J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1148\/radiol.2016151542","article-title":"Liver surface nodularity quantification from routine ct images as a biomarker for detection and evaluation of cirrhosis.","volume":"280","author":"Smith","year":"2016","journal-title":"Radiology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiol.2018181131","article-title":"Quantification of liver surface nodularity at ct: utility for detection of portal hypertension.","volume":"289","author":"Sartoris","year":"2018","journal-title":"Radiology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00261-019-02355-y","article-title":"Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between mri with hepatobiliary phase sequences and ct.","volume":"45","author":"De Vos","year":"2020","journal-title":"Abdom Radiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2013.09.002","article-title":"Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.","volume":"60","author":"Banerjee","year":"2014","journal-title":"J Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ehjci\/jev246","article-title":"Incremental value of quantitative cmr including parametric mapping for the diagnosis of acute myocarditis.","volume":"17","author":"Luetkens","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B54","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1148\/radiol.2018180051","article-title":"Quantification of liver fibrosis at t1 and t2 mapping with extracellular volume fraction mri: preclinical results.","volume":"288","author":"Luetkens","year":"2018","journal-title":"Radiology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00330-020-07080-5","article-title":"Magnetic resonance parametric mapping of the spleen for non-invasive assessment of portal hypertension.","volume":"31","author":"Mesropyan","year":"2021","journal-title":"Eur Radiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1002\/hep.32087","article-title":"A Machine learning approach to liver histological evaluation predicts clinically significant portal hypertension in nash cirrhosis.","volume":"74","author":"Bosch","year":"2021","journal-title":"Hepatology."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.863596","article-title":"Computed tomography-based texture features for the risk stratification of portal hypertension and prediction of survival in patients with cirrhosis: a preliminary study.","volume":"9","author":"Wan","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"B58","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0039-6109(03)00224-x","article-title":"Preoperative assessment of liver function.","volume":"84","author":"Schneider","year":"2004","journal-title":"Surg Clin North Am."},{"key":"B59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/hep.26700","article-title":"Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis.","volume":"59","author":"Lisotti","year":"2014","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/liv.13070","article-title":"Relationship between indocyanine green retention test, decompensation and survival in patients with child-pugh a cirrhosis and portal hypertension.","volume":"36","author":"Lisotti","year":"2016","journal-title":"Liver Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/meg.0000000000000611","article-title":"Indocyanine green retention test (icg-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.","volume":"28","author":"Pind","year":"2016","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s00268-021-06111-6","article-title":"Correlation between portal pressure and indocyanine green retention rate is unaffected by the cause of cirrhosis: a prospective study.","volume":"45","author":"Kobayashi","year":"2021","journal-title":"World J Surg."},{"key":"B63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/MOG.0000000000000167","article-title":"Noninvasive assessment of liver function.","volume":"31","author":"Helmke","year":"2015","journal-title":"Curr Opin Gastroenterol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/hep.510280406","article-title":"Doppler study of mesenteric, hepatic, and portal circulation in alcoholic cirrhosis: relationship between quantitative doppler measurements and the severity of portal hypertension and hepatic failure.","volume":"28","author":"Taourel","year":"1998","journal-title":"Hepatology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/j.1478-3231.2010.02326.x","article-title":"Haemodynamic evaluation by doppler ultrasonography in patients with portal hypertension: a review.","volume":"30","author":"Baik","year":"2010","journal-title":"Liver Int."},{"key":"B66","first-page":"1012","article-title":"Value of doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension.","volume":"92","author":"Iwao","year":"1997","journal-title":"Am J Gastroenterol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1148\/radiol.2401050585","article-title":"Renovascular impedance correlates with portal pressure in patients with liver cirrhosis.","volume":"240","author":"Berzigotti","year":"2006","journal-title":"Radiology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00535-010-0360-z","article-title":"Prognostic value of a single hvpg measurement and doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.","volume":"46","author":"Berzigotti","year":"2011","journal-title":"J Gastroenterol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1148\/radiol.2402051142","article-title":"Recent variceal bleeding: doppler us hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.","volume":"240","author":"Baik","year":"2006","journal-title":"Radiology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1478-3231.2007.01526.x","article-title":"Damping index of doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.","volume":"27","author":"Kim","year":"2007","journal-title":"Liver Int."},{"key":"B71","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S0720-048X(98)00057-6","article-title":"Ultrasound contrast agents: basic principles.","author":"Calliada","year":"1998","journal-title":"Eur J Radiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhep.2010.10.038","article-title":"Evaluation of regional hepatic perfusion (rhp) by contrast-enhanced ultrasound in patients with cirrhosis.","volume":"55","author":"Berzigotti","year":"2011","journal-title":"J Hepatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/hep.25752","article-title":"Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis.","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121601","article-title":"Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.","volume":"10","author":"Jeong","year":"2015","journal-title":"PLoS One."},{"key":"B75","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s00330-014-3476-3","article-title":"Impact of splenic circulation: non-invasive microbubble-based assessment of portal hemodynamics.","volume":"25","author":"Shimada","year":"2015","journal-title":"Eur Radiol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-5629(98)00163-X","article-title":"Pressure dependence of subharmonic signals from contrast microbubbles.","volume":"25","author":"Shi","year":"1999","journal-title":"Ultrasound Med Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1148\/radiol.13121769","article-title":"Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.","volume":"268","author":"Eisenbrey","year":"2013","journal-title":"Radiology."},{"key":"B78","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1148\/radiol.2020202677","article-title":"Diagnosing portal hypertension with noninvasive subharmonic pressure estimates from a us contrast agent.","volume":"298","author":"Gupta","year":"2021","journal-title":"Radiology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"464","DOI":"10.5009\/gnl16078","article-title":"Ultrasonography for noninvasive assessment of portal hypertension.","volume":"11","author":"Maruyama","year":"2017","journal-title":"Gut Liver."},{"key":"B80","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jhep.2013.12.015","article-title":"Accurate computed tomography-based portal pressure assessment in patients with hepatocellular carcinoma.","volume":"60","author":"Iranmanesh","year":"2014","journal-title":"J Hepatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1148\/radiol.2018180425","article-title":"Virtual hepatic venous pressure gradient with ct angiography (chess 1601): a prospective multicenter study for the noninvasive diagnosis of portal hypertension.","volume":"290","author":"Qi","year":"2019","journal-title":"Radiology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jhep.2017.07.037","article-title":"Insufficient. accuracy of computed tomography-based portal pressure assessment in hepatitis b virus-related cirrhosis: an analysis of data from chess-1601 trial.","volume":"68","author":"Qi","year":"2017","journal-title":"J Hepatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jhep.2017.08.031","article-title":"Reply To.: \u201cinsufficient accuracy of computed tomography-based portal pressure assessment in hepatitis b virus-related cirrhosis: an analysis of data from chess-1601 trial\u201d.","volume":"68","author":"Iranmanesh","year":"2017","journal-title":"J Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1148\/radiol.2292021128","article-title":"Hepatic flow parameters measured with mr imaging and doppler us: correlations with degree of cirrhosis and portal hypertension.","volume":"229","author":"Annet","year":"2003","journal-title":"Radiology."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jhep.2016.07.021","article-title":"Non-Invasive assessment of portal hypertension using quantitative magnetic resonance imaging.","volume":"65","author":"Palaniyappan","year":"2016","journal-title":"J Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1007\/s00330-020-07495-0","article-title":"Noninvasive diagnosis of portal hypertension using gadoxetate dce-mri of the liver and spleen.","volume":"31","author":"Hectors","year":"2021","journal-title":"Eur Radiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00330-015-3991-x","article-title":"Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2d-cine phase-contrast magnetic resonance imaging.","volume":"26","author":"Gouya","year":"2016","journal-title":"Eur Radiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/rli.0000000000000328","article-title":"Caval subtraction 2d phase-contrast mri to measure total liver and hepatic arterial blood flow: proof-of-principle, correlation with portal hypertension severity and validation in patients with chronic liver disease.","volume":"52","author":"Chouhan","year":"2017","journal-title":"Invest Radiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/RLI.0000000000000366","article-title":"Effects of portal hypertension on gadoxetic acid-enhanced liver magnetic resonance: diagnostic and prognostic implications.","volume":"52","author":"Asenbaum","year":"2017","journal-title":"Invest Radiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-bioeng-100219-110055","article-title":"4d Flow with Mri.","volume":"22","author":"Soulat","year":"2020","journal-title":"Annu Rev Biomed Eng."},{"key":"B91","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/jmri.26305","article-title":"Hemodynamic measurements with an abdominal 4d flow mri sequence with spiral sampling and compressed sensing in patients with chronic liver disease.","volume":"49","author":"Bane","year":"2019","journal-title":"J Magn Reson Imaging."},{"key":"B92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1148\/radiol.2018180230","article-title":"Four-Dimensional flow mri as a marker for risk stratification of gastroesophageal varices in patients with liver cirrhosis.","volume":"290","author":"Motosugi","year":"2019","journal-title":"Radiology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1148\/radiol.11110127","article-title":"Normal and altered three-dimensional portal venous hemodynamics in patients with liver cirrhosis.","volume":"262","author":"Stankovic","year":"2012","journal-title":"Radiology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00261-020-02729-7","article-title":"Noninvasive imaging assessment of portal hypertension.","volume":"45","author":"Kennedy","year":"2020","journal-title":"Abdom Radiol (NY)."},{"key":"B95","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1148\/radiol.2015141941","article-title":"Assessment of hepatic vascular network connectivity with automated graph analysis of dynamic contrast-enhanced us to evaluate portal hypertension in patients with cirrhosis: a pilot study.","volume":"277","author":"Amat-Roldan","year":"2015","journal-title":"Radiology."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/lt.20857","article-title":"Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis c recurrence after liver transplantation.","volume":"12","author":"Carri\u00f3n","year":"2006","journal-title":"Liver Transplant."},{"key":"B97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ultrasmedbio.2016.07.025","article-title":"A Meta-Analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension.","volume":"43","author":"You","year":"2017","journal-title":"Ultrasound Med Biol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2017.02.003","article-title":"Non-Invasive evaluation of portal hypertension using ultrasound elastography.","volume":"67","author":"Berzigotti","year":"2017","journal-title":"J Hepatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the baveno vi consensus workshop: stratifying risk and individualizing care for portal hypertension.","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease.","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2021.09.029","article-title":"Overlooked subclinical portal hypertension in non-cirrhotic nafld: is it real and how to measure it?","volume":"76","author":"Baffy","year":"2022","journal-title":"J Hepatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","article-title":"Update to the society of radiologists in ultrasound liver elastography consensus statement.","volume":"296","author":"Barr","year":"2020","journal-title":"Radiology."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/hep.21665","article-title":"Liver stiffness measurement predicts severe portal hypertension in patients with hcv-related cirrhosis.","volume":"45","author":"Vizzutti","year":"2007","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B104","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","article-title":"Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients.","volume":"14","author":"Marasco","year":"2020","journal-title":"Hepatol Int."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following hcv eradication with oral antiviral therapy in patients with clinically significant portal hypertension.","volume":"73","author":"Lens","year":"2020","journal-title":"J Hepatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with hcv-related cirrhosis.","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1007\/s00330-020-07223-8","article-title":"Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis.","volume":"31","author":"Hu","year":"2021","journal-title":"Eur Radiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","article-title":"Non-Invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.","volume":"70","author":"Kim","year":"2019","journal-title":"J Hepatol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/jgh.13907","article-title":"Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt.","volume":"33","author":"De Santis","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.28610","article-title":"Successful antiviral treatment of chronic hepatitis c leads to a rapid decline of liver stiffness without an early effect on spleen stiffness.","volume":"64","author":"Verlinden","year":"2016","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1016\/j.ultrasmedbio.2018.07.008","article-title":"Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations.","volume":"44","author":"Ferraioli","year":"2018","journal-title":"Ultrasound Med Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1148\/radiol.2018170601","article-title":"Quantitative elastography methods in liver disease: current evidence and future directions.","volume":"286","author":"Kennedy","year":"2018","journal-title":"Radiology."},{"key":"B113","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/liv.14228","article-title":"A Novel Spleen-Dedicated Stiffness Measurement by Fibroscan\u00ae Improves the Screening of High-Risk Oesophageal Varices.","volume":"40","author":"Stefanescu","year":"2020","journal-title":"Liver Int."},{"key":"B114","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/apt.14488","article-title":"Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis.","volume":"47","author":"Elkrief","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/hep4.1855","article-title":"The value of liver and spleen stiffness for evaluation of portal hypertension in compensated cirrhosis.","volume":"6","author":"Reiberger","year":"2021","journal-title":"Hepatol Commun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/liv.13243","article-title":"Shear-Wave elastography of the liver and spleen identifies clinically significant portal hypertension: a prospective multicentre study.","volume":"37","author":"Jansen","year":"2017","journal-title":"Liver Int."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy.","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001664","article-title":"Derivation. and validation of a model to predict clinically significant portal hypertension using transient elastography and fib-4.","author":"Banini","year":"2022","journal-title":"J Clin Gastroenterol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00330-015-3949-z","article-title":"Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.","volume":"26","author":"Singh","year":"2016","journal-title":"Eur Radiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/jmri.24049","article-title":"Hepatic and splenic stiffness augmentation assessed with mr elastography in an in vivo porcine portal hypertension model.","volume":"38","author":"Yin","year":"2013","journal-title":"J Magn Reson Imaging."},{"key":"B121","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1148\/radiol.2021202804","article-title":"Three-Dimensional Mr elastography depicts liver inflammation, fibrosis, and portal hypertension in chronic hepatitis b or c.","volume":"301","author":"Shi","year":"2021","journal-title":"Radiology."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1111\/liv.14981","article-title":"Using mr elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.","volume":"41","author":"Danielsen","year":"2021","journal-title":"Liver Int."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jmri.26026","article-title":"Noninvasive prediction of portal pressure with mr elastography and dce-mri of the liver and spleen: preliminary results.","volume":"48","author":"Wagner","year":"2018","journal-title":"J Magn Reson Imaging."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/jgh.14271","article-title":"Accuracy of liver stiffness, spleen stiffness, and ls-spleen diameter to platelet ratio score in detection of esophageal varices: systemic review and meta-analysis.","volume":"33","author":"Manatsathit","year":"2018","journal-title":"J Gastroenterol Hepatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/hep.31462","article-title":"Noninvasive risk stratification after hcv eradication in patients with advanced chronic liver disease.","volume":"73","author":"Semmler","year":"2020","journal-title":"Hepatology (Baltimore, Md)."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.14309\/ajg.0000000000000722","article-title":"Deciding among noninvasive tools for predicting varices needing treatment in chronic liver disease: an analysis of asian cohort.","volume":"115","author":"Sharma","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-2444","article-title":"Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign.","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1136\/gut.52.8.1200","article-title":"Platelet count\/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis.","volume":"52","author":"Giannini","year":"2003","journal-title":"Gut."},{"key":"B129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/00365515309094199","article-title":"Estimation of portal venous pressure by occlusive hepatic vein catheterization.","volume":"5","author":"Krook","year":"1953","journal-title":"Scand J Clin Lab Invest."},{"key":"B130","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.dld.2005.02.009","article-title":"Assessment of the agreement between wedge hepatic vein pressure and portal vein pressure in cirrhotic patients.","volume":"37","author":"Thalheimer","year":"2005","journal-title":"Dig Liver Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/s0016-5107(03)02544-6","article-title":"Eus-Guided portal vein catheterization and pressure measurement in an animal model: a pilot study of feasibility.","volume":"59","author":"Lai","year":"2004","journal-title":"Gastrointest Endosc."},{"key":"B132","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.gie.2016.09.026","article-title":"Eus-Guided Portal Pressure Gradient Measurement with a Simple Novel Device: A Human Pilot Study.","volume":"85","author":"Huang","year":"2017","journal-title":"Gastrointest Endosc."},{"key":"B133","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5582\/ddt.2019.01009","article-title":"Impact of non-selective beta blockers on portal hypertension and hepatic elasticity in hepatitis c virus-related liver cirrhosis.","volume":"13","author":"Zaghloul","year":"2019","journal-title":"Drug Discov Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"731","DOI":"10.4254\/wjh.v10.i10.731","article-title":"Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis c virus patients.","volume":"10","author":"Ravaioli","year":"2018","journal-title":"World J Hepatol."},{"key":"B135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver Fibrosis.","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest."},{"key":"B136","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-Invasive evaluation of liver fibrosis using transient elastography.","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Easl-Aleh clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis.","volume":"63","year":"2015","journal-title":"J Hepatol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive Methods to Assess Liver Disease in Patients with Hepatitis B or C.","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.ultrasmedbio.2015.03.007","article-title":"Wfumb guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver.","volume":"41","author":"Ferraioli","year":"2015","journal-title":"Ultrasound Med Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography.","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology."},{"key":"B141","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. i. portal hypertension.","author":"Bosch","year":"2000","journal-title":"J Hepatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.960316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T08:41:07Z","timestamp":1663231267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.960316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":141,"alternative-id":["10.3389\/fmed.2022.960316"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.960316","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"article-number":"960316"}}